Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | California Capital Equity, LLCUnternehmen | 4,61M | 25,00M | Derivative Exercise and Retained Stock | 5,43 | 259,00M | 1,81% |
| 2026-02-24 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -75,00k | 900,79k | Automatic Disposition | 12,01 | 2,85M | -2,56% |
| 2026-02-23 | Ms. Christobel E. SeleckyIndependent Director | -25,00k | 175,50k | Derivative Exercise and Sale | 2,98 - 10,00 | 0,00 | - |
| 2026-02-22 | Ms. Regan J. LauerCAO | 2,39k | 0,00 | Derivative Exercise and Retained Stock | - | 115,88k | 2,11% |
| 2026-02-22 | Ms. Regan J. LauerCAO | -1,67k | 14,56k | Derivative Exercise and Sale | 8,70 | 115,88k | - |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | 74,88k | 0,00 | Derivative Exercise and Retained Stock | - | 560,34k | 15,42% |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | -77,56k | 674,77k | Derivative Exercise and Sale | 8,70 | 560,34k | - |
| 2026-02-22 | Mr. David C. SachsCFO | 19,97k | 0,00 | Derivative Exercise and Retained Stock | - | 300,14k | 7,13% |
| 2026-02-22 | Mr. David C. SachsCFO | -20,68k | 179,93k | Derivative Exercise and Sale | 8,70 | 300,14k | - |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 56,16k | 0,00 | Derivative Exercise and Retained Stock | - | 291,46M | 0,02% |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -58,17k | 506,08k | Derivative Exercise and Sale | 8,70 | 291,46M | - |
| 2026-02-22 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -15,24k | 146,89k | Derivative Exercise and Sale | 8,70 - 10,25 | 2,93M | - |
| 2026-02-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -165,78k | 1,69M | Automatic Disposition | 9,25 - 10,25 | 2,93M | -5,36% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 155,56k | 0,00 | Derivative Exercise and Retained Stock | - | 291,41M | 0,05% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -118,56k | 821,62k | Derivative Exercise and Sale | 6,93 | 291,41M | - |
| 2026-02-10 | Mr. David C. SachsCFO | 39,59k | 0,00 | Derivative Exercise and Retained Stock | - | 280,18k | 16,46% |
| 2026-02-10 | Mr. David C. SachsCFO | -42,64k | 295,52k | Derivative Exercise and Sale | 6,93 | 280,18k | - |
| 2026-02-10 | Ms. Regan J. LauerCAO | 3,23k | 0,00 | Derivative Exercise and Retained Stock | - | 113,48k | 2,92% |
| 2026-02-10 | Ms. Regan J. LauerCAO | -2,26k | 15,64k | Derivative Exercise and Sale | 6,93 | 113,48k | - |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | 134,07k | 0,00 | Derivative Exercise and Retained Stock | - | 485,47k | 38,16% |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | -140,05k | 970,53k | Derivative Exercise and Sale | 6,93 | 485,47k | - |
| 2026-01-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -151,97k | 1,09M | Automatic Disposition | 6,54 - 7,88 | 3,09M | -4,69% |
| 2026-01-16 | Ms. Christobel E. SeleckyIndependent Director | -75,00k | 214,15k | Derivative Exercise and Sale | 2,98 - 7,51 | 0,00 | - |
| 2025-12-31 | Mr. David C. SachsCFO | 14,96k | 0,00 | Derivative Exercise and Retained Stock | - | 240,58k | 6,63% |
| 2025-12-31 | Mr. David C. SachsCFO | -15,44k | 30,56k | Derivative Exercise and Sale | 1,98 | 240,58k | - |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | 16,97k | 0,00 | Derivative Exercise and Retained Stock | - | 351,39k | 5,08% |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | -17,51k | 34,67k | Derivative Exercise and Sale | 1,98 | 351,39k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
